Drug intelligence / Profile preview

Zhuanyaotang Decoction

Development stage: Unknown
Lead developer: 中国中医科学院望京医院
Modality: Small Molecules
Administration: Oral

Overview

Zhuanyaotang Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed by Wang Jing Hospital of the Chinese Academy of Traditional Chinese Medicine. It is primarily investigated for the treatment of symptomatic degenerative lumbar spinal stenosis (DLSS), specifically targeting the 'spleen-kidney qi deficiency with phlegm and blood stasis' pattern according to TCM diagnostic principles. The decoction is typically administered as granules. In clinical studies, it has been evaluated for its ability to provide symptomatic relief and functional improvement, often compared against standard treatments like mecobalamin and celecoxib.

Other names: ZhuanyaotangZhuanyaotang granules

Beyond the preview

Go deeper on Zhuanyaotang Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhuanyaotang Decoction.

Explore the full profile